Rutgers & Posch advises founders on sale of Luscii Healthtech, a fast-growing scale-up in the field of digital health and remote consultation service platforms, to Omron Healthcare

8 April 2024

Luscii Healthtech was founded in 2018. Omron Healthcare, a global leader in the field of clinically proven, innovative medical equipment for home health monitoring and treatment, took part in the initial seed funding of Luscii Healthtech. Luscii Healthtech is the market leader in the Netherlands, where it collaborates with approximately 70% of the hospitals. In recent years it has extended the presence of its platform to other markets, including the UK, Germany and various other countries in Europe and Africa.

Rutgers & Posch advised the founders in the seed funding round in 2018 and now also on the full sale to Omron Healthcare. The team consisted of Matthijs van den Broek and Rosanne Schut.

The transaction is another strong example of Rutgers & Posch expertise in technology M&A transactions, including healthtech.

More information can be read via the buttons below.